IP Library Assignment 026779/0602
Patent Assignment
Reel/Frame 026779/0602

Change of Name

Recorded: 2011-08-19 Pages: 3
Assignor
EYETECH PHARMACEUTICALS, INC.
Executed: 2005-11-14
Assignee
(OSI) EYETECH, INC.
3 TIMES SQUARE, 12TH FLOOR, NEW YORK, NEW YORK, 10036
Covered Properties (4)
Combination Therapy for the Treatment of Ocular Neovascular Disorders
Patent: 8,206,707 →
Application: 12/465,051 →
Publication: US 2010/0111942
Combination Therapy for the Treatment of Ocular Neovascular Disorders
Patent: 8,187,597 →
Application: 12/564,863 →
Publication: US 2010/0119522
Combination Therapy for the Treatment of Ocular Neovascular Disorders
Patent: 8,685,397 →
Application: 12/641,270 →
Publication: US 2010/0129364
Combination Therapy for the Treatment of Ocular Neovascular Disorders
Application: 12/987,508 →
Publication: US 2011/0200593
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 17, 2009
From: SHIMA, DAVID T.; CALIAS, PERRY; ADAMIS, ANTHONY P.
To: OPHTOTECH CORPORATION
Reel/Frame 023727/0177 →
Assignment of Assignor's Interest Aug 19, 2011
From: SHIMA, DAVID T.; CALIAS, PERRY; ADAMIS, ANTHONY P.
To: EYETECH PHARMACEUTICALS, INC.
Reel/Frame 026779/0547 →
Assignment of Assignor's Interest Aug 19, 2011
From: (OSI) EYETECH, INC.
To: OPHTHOTECH CORPORATION
Reel/Frame 026779/0582 →
Assignment of Assignor's Interest Mar 27, 2012
From: (OSI) EYETECH, INC.
To: OPHTHOTECH CORPORATION
Reel/Frame 027939/0028 →
To Correct an Error in a Cover Sheet Previously Recorded at Reel 023727, Frame 0177, by Replacing the Receiving Party Name "Ophtotech Corporation" and Its Address with "Eyetech Pharmaceuticals, Inc." and Its Address. See Attached. Mar 27, 2012
From: SHIMA, DAVID T.; CALIAS, PERRY; ADAMIS, ANTHONY P.
To: EYETECH PHARMACEUTICALS, INC.
Reel/Frame 027941/0646 →